Literature DB >> 20526398

A case of diabetic neuropathy combined with Guillain-Barre syndrome.

Heung-Yong Jin1, Kyung-Ae Lee, So-Young Kim, Ji-Hyun Park, Hong-Sun Baek, Tae-Sun Park.   

Abstract

A 59-year-old man was admitted with numbness, pain, and a tingling sensation in both lower legs. He was initially diagnosed with diabetic peripheral neuropathy based on a symptom questionnaire and a quantitative sensory test. Despite symptomatic treatment of diabetic neuropathy, he complained of worsening sensory symptoms and additional motor weakness in both lower extremities. As the motor weakness of both extremities became more aggravated over time, brain and spine imaging tests and a nerve conduction test were performed. The nerve conduction study revealed motor and sensory axonal neuropathy. In his cerebrospinal analysis, albumino-cytologic dissociation, which is compatible to the Gillian-Barre syndrome, was found. Cerebrospinal fluid analysis showed albumino-cytologic dissociation. He was treated with intravenous immunoglobulin and his neurologic deficits were gradually improved.

Entities:  

Keywords:  Diabetes mellitus; Diabetic neuropathy; Guillain-Barre syndrome

Mesh:

Year:  2010        PMID: 20526398      PMCID: PMC2880698          DOI: 10.3904/kjim.2010.25.2.217

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  12 in total

Review 1.  Pain: moving from symptom control toward mechanism-specific pharmacologic management.

Authors:  Clifford J Woolf
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

Review 2.  The Guillain-Barré syndrome.

Authors:  A H Ropper
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

Review 3.  Diabetic neuropathies: a statement by the American Diabetes Association.

Authors:  Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

Review 4.  Guillain-Barré syndrome.

Authors:  A F Hahn
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

5.  Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.

Authors:  J D Stewart; R McKelvey; L Durcan; S Carpenter; G Karpati
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

6.  Guillain-Barré syndrome occurring in two women after ketoacidosic comatose state disclosing an insulin-dependent diabetes mellitus.

Authors:  M Rouanet-Larriviere; C Vital; P Arne; J C Favarel-Garrigues; H Gin; A Vital
Journal:  J Peripher Nerv Syst       Date:  2000-03       Impact factor: 3.494

7.  Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.

Authors:  G Kanra; A Ozon; J Vajsar; L Castagna; G Secmeer; H Topaloglu
Journal:  Eur J Paediatr Neurol       Date:  1997       Impact factor: 3.140

Review 8.  Pathogenesis of Guillain-Barré syndrome.

Authors:  R A Hughes; R D Hadden; N A Gregson; K J Smith
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

Review 9.  An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms.

Authors:  Robert H Dworkin
Journal:  Clin J Pain       Date:  2002 Nov-Dec       Impact factor: 3.442

10.  Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.

Authors:  A J Boulton; F A Gries; J A Jervell
Journal:  Diabet Med       Date:  1998-06       Impact factor: 4.359

View more
  2 in total

Review 1.  Exploring the molecular role of endostatin in diabetic neuropathy.

Authors:  Tuhin Mukherjee; Tapan Behl; Aayush Sehgal; Saurabh Bhatia; Harmanpreet Singh; Simona Bungau
Journal:  Mol Biol Rep       Date:  2021-02-09       Impact factor: 2.316

2.  Looks Like Neurosyphilis, Feels Like Guillain-Barre: At the Confluence of Infection and Immunology.

Authors:  Joseph I Berger; Kasun Vernon; Farid Abdo; Sandeep Gulati; Radhika Hariharan
Journal:  Cureus       Date:  2022-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.